BioLargo Management

Management criteria checks 4/4

BioLargo's CEO is Dennis Calvert, appointed in Jun 2002, has a tenure of 22.5 years. total yearly compensation is $316.59K, comprised of 91.2% salary and 8.8% bonuses, including company stock and options. directly owns 2.77% of the company’s shares, worth $1.63M. The average tenure of the management team and the board of directors is 19.3 years and 17.7 years respectively.

Key information

Dennis Calvert

Chief executive officer

US$316.6k

Total compensation

CEO salary percentage91.2%
CEO tenure22.5yrs
CEO ownership2.8%
Management average tenure19.3yrs
Board average tenure17.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dennis Calvert's remuneration changed compared to BioLargo's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$2m

Jun 30 2024n/an/a

-US$3m

Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$317kUS$289k

-US$4m

Sep 30 2023n/an/a

-US$4m

Jun 30 2023n/an/a

-US$3m

Mar 31 2023n/an/a

-US$3m

Dec 31 2022US$456kUS$289k

-US$4m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$7m

Mar 31 2022n/an/a

-US$7m

Dec 31 2021US$651kUS$289k

-US$7m

Sep 30 2021n/an/a

-US$6m

Jun 30 2021n/an/a

-US$7m

Mar 31 2021n/an/a

-US$8m

Dec 31 2020US$709kUS$289k

-US$8m

Sep 30 2020n/an/a

-US$9m

Jun 30 2020n/an/a

-US$11m

Mar 31 2020n/an/a

-US$10m

Dec 31 2019US$656kUS$289k

-US$11m

Sep 30 2019n/an/a

-US$10m

Jun 30 2019n/an/a

-US$9m

Mar 31 2019n/an/a

-US$10m

Dec 31 2018US$656kUS$289k

-US$10m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$10m

Mar 31 2018n/an/a

-US$9m

Dec 31 2017US$534kUS$289k

-US$9m

Compensation vs Market: Dennis's total compensation ($USD316.59K) is below average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Dennis's compensation has been consistent with company performance over the past year.


CEO

Dennis Calvert (61 yo)

22.5yrs

Tenure

US$316,593

Compensation

Mr. Dennis P. Calvert serves as the Chairman of the Board at BioLargo, Inc. and has been its Chief Executive Officer and President since June 28, 2002. Mr. Calvert has an extensive entrepreneurial backgrou...


Leadership Team

NamePositionTenureCompensationOwnership
Dennis Calvert
Chairman22.5yrsUS$316.59k2.77%
$ 1.6m
Charles Dargan
Chief Financial Officer16.8yrsUS$140.85k0.063%
$ 37.1k
Joseph Provenzano
Executive VP of Operations21.8yrsUS$258.65k0.56%
$ 329.2k
Kenneth Code
Chief Science Officer & Directorno dataUS$301.20k0.97%
$ 570.3k
Alex Evans
Director of Corporate Communications1.3yrsno datano data
Steven Harrison
President of Clyra Medical Technologies Incno dataUS$30.24kno data
Randall Moore
President of BioLargo Engineeringno datano datano data
Richard Smith
President of BioLargo Canadano datano datano data
Tonya Chandler
President of BioLargo Equipment Solutions & Technologiesno datano datano data

19.3yrs

Average Tenure

65yo

Average Age

Experienced Management: BLGO's management team is seasoned and experienced (19.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Dennis Calvert
Chairman22.5yrsUS$316.59k2.77%
$ 1.6m
Joseph Provenzano
Executive VP of Operations22.5yrsUS$258.65k0.56%
$ 329.2k
Kenneth Code
Chief Science Officer & Director17.7yrsUS$301.20k0.97%
$ 570.3k
Dennis Marshall
Independent Director18.7yrsUS$154.83k0.086%
$ 50.7k
Jack Strommen
Independent Director7.5yrsUS$56.16k1.62%
$ 951.6k
Linda Park
Independent Director2.1yrsUS$70.20k0.063%
$ 37.1k
Christina Bray
Independent Director2.1yrsUS$70.20k0%
$ 0

17.7yrs

Average Tenure

55yo

Average Age

Experienced Board: BLGO's board of directors are seasoned and experienced ( 17.7 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:32
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BioLargo, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard RyanOak Ridge Financial Services Group Inc.